Effects of Ketone Supplementation on Acute Alcohol Withdrawal

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pennsylvania
Study ID
NCT06173973
Phase
PHASE2/PHASE3
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Kenetik; Ketone Concentrate — DIETARY_SUPPLEMENT
    Ketone Supplement
  • Isocaloric dextrose placebo — DIETARY_SUPPLEMENT
    Drink that is taste and visually matched to Ketone supplement

Study Details

The goal of this study is to study the effects of the ketone supplement Kenetik compared to placebo (an inactive beverage) on alcohol withdrawal symptoms during the 5 days of clinical alcohol withdrawal management treatment at the Caron Treatment Center.

Key Dates

Start date
Mar 11, 2024
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Active Comparator: Ketone Supplement
    Ketone Supplement drink with 10 g ketones three times daily for five days.
  • Placebo Comparator: Placebo Beverage
    Matching Placebo drink three times daily for five days

Primary Outcome Measure

Effects of ketone supplement Kenetik, three times daily (TID), versus placebo, on the need for benzodiazepines (daily use in mg). [ Time Frame: 5 days ]

Locations (2)

FacilityCityStateZIPSite coordinators
University of Pennsylvania Center for Studies of AddictionPhiladelphiaPennsylvania19104-
Caron Treatment CenterWernersvillePennsylvania19565-

Find similar trials in Philadelphia, PA

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
University of Pennsylvania Center for Studies of Addiction· Philadelphia, PACaron Treatment Center· Wernersville, PA

Related Studies